Catalogue number: | I7663-35D |
Size: | 2ug |
Form: | Supplied as a lyophilized powder. Reconstitute with sterile dH2O PBS to 0.1-1mg/ml, which can be further diluted into other aqueous solutions. |
Purity: | (same/more than) 95% as determined by RP-HPLC; Reducing and non-reducing SDS-PAGE. |
References: | 1. Effect of allergen-specific immunotherapy on recombinant human interleukin 3-mediated amplification of allergen-induced basophil histamine release. Allergy Asthma Proc 2005 Nov-Dec;26(6):456-62 2. Secretion of functional human interleukin-3 from Bacillus subtilis. J Biotechnol 2006 May 17;123(2):211-24 3. Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression. Blood 2005 Oct 1;106(7):2527-9 4. Toxicology and pharmacokinetics of DT388IL3, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human interleukin 3 (IL3), in cynomolgus monkeys. Leuk Lymphoma 2004 Aug;45(8):1647-56 5. [Radioprotection of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor on peripheral lymphocytes of rhesus monkey irradiated by 3.0 Gy gamma-rays] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004 Jan;16(1):22-5 6. Molecular cloning, expression, purification, and characterization of soluble full-length, human interleukin-3 with a baculovirus-insect cell expression system. Protein Expr Purif 2003 Sep;31(1):34-41 |